CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Return
34.55%
This Quarter Return
+8.43%
1 Year Return
+34.55%
3 Year Return
+41.71%
5 Year Return
+124.92%
10 Year Return
+254.42%
AUM
$100B
AUM Growth
+$2.09B
(+2.1%)
Cap. Flow
-$3.44B
Cap. Flow
% of AUM
-3.43%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
3,336
New
85
Increased
1,932
Reduced
949
Closed
178
Top Buys
| 1 |
Indivior
INDV
|
+$326M |
| 2 |
Burford Capital
BUR
|
+$152M |
| 3 |
Vale
VALE
|
+$86M |
| 4 |
Comcast
CMCSA
|
+$79M |
| 5 |
Mercado Libre
MELI
|
+$68.7M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Apple
AAPL
|
+$212M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$200M |
| 4 |
JPMorgan Chase
JPM
|
+$165M |
| 5 |
Cisco
CSCO
|
+$134M |
Sector Composition
| 1 | Technology | 25.9% |
| 2 | Healthcare | 15.79% |
| 3 | Financials | 13.41% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Industrials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Buckle
BKE
$3.04B
| $1.77M | ﹤0.01% |
51,160
+9,940
| +24% | +$344K |
|
|
ICPT
1927
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.77M | ﹤0.01% |
159,756
+32,793
| +26% | +$363K |
|
1928
Ultra Clean Holdings
UCTT
$1.14B
| $1.77M | ﹤0.01% |
45,930
+5,582
| +14% | +$215K |
|
1929
Arcturus Therapeutics
ARCT
$470M
| $1.77M | ﹤0.01% |
61,546
+18,571
| +43% | +$533K |
|
1930
Delek US
DK
$1.68B
| $1.76M | ﹤0.01% |
73,645
+120
| +0.2% | +$2.87K |
|
1931
Hilltop Holdings
HTH
$2.18B
| $1.76M | ﹤0.01% |
56,028
+7,302
| +15% | +$230K |
|
1932
Peabody Energy
BTU
$2.24B
| $1.76M | ﹤0.01% |
81,133
+6,686
| +9% | +$145K |
|
1933
US Physical Therapy
USPH
$1.22B
| $1.75M | ﹤0.01% |
14,454
-953
| -6% | -$116K |
|
1934
Wabash National
WNC
$457M
| $1.75M | ﹤0.01% |
68,422
+10,828
| +19% | +$278K |
|
1935
Northwest Bancshares
NWBI
$1.83B
| $1.75M | ﹤0.01% |
165,243
+55,502
| +51% | +$588K |
|
1936
ReNew
RNW
$2.76B
| $1.75M | ﹤0.01% |
319,059
+15,621
| +5% | +$85.6K |
|
1937
IMAX
IMAX
$1.74B
| $1.75M | ﹤0.01% |
102,904
+22,050
| +27% | +$375K |
|
1938
Compass Diversified
CODI
$527M
| $1.75M | ﹤0.01% |
80,526
-17,009
| -17% | -$369K |
|
1939
Driven Brands
DRVN
$3B
| $1.75M | ﹤0.01% |
64,505
+19,151
| +42% | +$518K |
|
1940
Century Aluminum
CENX
$2.44B
| $1.74M | ﹤0.01% |
199,784
+27,481
| +16% | +$240K |
|
1941
Rocket Pharmaceuticals
RCKT
$341M
| $1.74M | ﹤0.01% |
87,596
+16,865
| +24% | +$335K |
|
1942
Kimbell Royalty Partners
KRP
$1.26B
| $1.74M | ﹤0.01% |
118,069
+31,706
| +37% | +$466K |
|
1943
Protagonist Therapeutics
PTGX
$3.66B
| $1.74M | ﹤0.01% |
62,834
+24,833
| +65% | +$686K |
|
1944
Tredegar Corp
TG
$279M
| $1.73M | ﹤0.01% |
260,000
-22,255
| -8% | -$148K |
|
1945
Chefs' Warehouse
CHEF
$2.7B
| $1.73M | ﹤0.01% |
48,439
+8,872
| +22% | +$317K |
|
1946
Dine Brands
DIN
$368M
| $1.73M | ﹤0.01% |
29,834
+6,288
| +27% | +$365K |
|
1947
Standex International
SXI
$2.47B
| $1.73M | ﹤0.01% |
12,231
+1,454
| +13% | +$206K |
|
1948
Celldex Therapeutics
CLDX
$1.62B
| $1.73M | ﹤0.01% |
50,870
+14,616
| +40% | +$496K |
|
1949
Dillards
DDS
$8.97B
| $1.72M | ﹤0.01% |
5,285
-132
| -2% | -$43.1K |
|
1950
Syndax Pharmaceuticals
SNDX
$1.34B
| $1.72M | ﹤0.01% |
82,388
+26,689
| +48% | +$559K |
|